An experimental HIV vaccine based on mRNA — the same platform technology used in two highly effective COVID-19 vaccines — shows promise in mice and non-human primates, according to scientists. Their results show that the novel vaccine was safe and prompted desired antibody and cellular immune responses against an HIV-like virus.